CD4+ Th1 cells activated CD8+ T cells, and γδ-T cells are typically implicated in type I immune responses and are associated with a favorable prognosis in patients with lung cancer (Schalper et al., 2015; Bremnes et al., 2016). This evidence concerns the gene CD4 and lung carcinoma.